These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21388257)

  • 1. Bioanalysis of biotherapeutics at a crossroad.
    Ezan E
    Bioanalysis; 2011 Mar; 3(5):469-71. PubMed ID: 21388257
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of matrix-associated soluble factors on the specificity of the immunogenicity assessment.
    Bautista AC; Wullner D; Moxness M; Swanson SJ; Chirmule N; Jawa V
    Bioanalysis; 2010 Apr; 2(4):721-31. PubMed ID: 21083270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic and analytic considerations in the design of immunoassays.
    Weinryb I; Shroff JR; Olson DR
    Drug Metab Rev; 1979; 10(2):271-83. PubMed ID: 233213
    [No Abstract]   [Full Text] [Related]  

  • 4. How the bioanalytical scientist plays a key role in interdisciplinary project teams in the development of biotherapeutics - a reflection of the European Bioanalysis Forum.
    Dudal S; Staack RF; Stoellner D; Fjording MS; Vieser E; Pascual MH; Brudny-Kloeppel M; Golob M
    Bioanalysis; 2014 May; 6(10):1339-48. PubMed ID: 24958118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One size does not fit all.
    Kelley M
    Bioanalysis; 2011 Mar; 3(5):473-5. PubMed ID: 21388258
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioanalysis-related highlights from the 2011 AAPS National Biotechnology Conference.
    Crisino RM; Dulanto B
    Bioanalysis; 2011 Aug; 3(16):1809-14. PubMed ID: 21877889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of metabolite testing in regulated bioanalysis.
    Garofolo F; Savoie N; Bergeron A; Amestoy C; Lefebvre M; Caillé L; Furtado M; Menard C
    Bioanalysis; 2010 Jul; 2(7):1171-4. PubMed ID: 21083229
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular imprinting for drug bioanalysis. A review on the application of imprinted polymers to solid-phase extraction and binding assay.
    Andersson LI
    J Chromatogr B Biomed Sci Appl; 2000 Feb; 739(1):163-73. PubMed ID: 10744324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Welcome to MIST and bioanalysis. Foreword.
    Chaudhary A
    Bioanalysis; 2010 Jul; 2(7):1169-70. PubMed ID: 21083228
    [No Abstract]   [Full Text] [Related]  

  • 10. Conference report: European Bioanalysis Forum.
    Abbott RW; Brudny-Kloeppel M
    Bioanalysis; 2009 May; 1(2):273-6. PubMed ID: 21083164
    [No Abstract]   [Full Text] [Related]  

  • 11. The immunological assay of drugs.
    Butler VP
    Pharmacol Rev; 1977 Jun; 29(2):103-84. PubMed ID: 353828
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug bioanalysis and biomarker discovery at the Commissariat à l'énergie atomique et aux énergies alternatives.
    Ezan E; Becher F; Benech H; Fenaille F; Junot C; Mabondzo A; Pruvost A
    Bioanalysis; 2010 Apr; 2(4):713-7. PubMed ID: 21083268
    [No Abstract]   [Full Text] [Related]  

  • 13. Insights in regulated bioanalysis of human insulin and insulin analogs by immunoanalytical methods.
    Bowsher RR; Nowatzke WL
    Bioanalysis; 2011 Apr; 3(8):883-98. PubMed ID: 21510762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The historical role of gas chromatography in bioanalysis.
    Chamberlain J
    Bioanalysis; 2010 Feb; 2(2):167-9. PubMed ID: 21083297
    [No Abstract]   [Full Text] [Related]  

  • 15. Biotherapeutic bioanalysis: a multi-indication case study review.
    Myler HA; Given A; Kolz K; Mora JR; Hristopoulos G
    Bioanalysis; 2011 Mar; 3(6):623-43. PubMed ID: 21417732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Singlicate analysis in regulated bioanalysis using ligand-binding assays: where are we heading?
    Birnboeck HF; Schick E; Justies N
    Bioanalysis; 2017 Sep; 9(18):1357-1359. PubMed ID: 28920450
    [No Abstract]   [Full Text] [Related]  

  • 17. Overview of metabolite safety testing from an industry perspective.
    Anderson S; Knadler MP; Luffer-Atlas D
    Bioanalysis; 2010 Jul; 2(7):1249-61. PubMed ID: 21083238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel LC-MS approach for the detection of metabolites in DMPK studies.
    Plumb RS; Mather J; Little D; Rainville PD; Twohig M; Harland G; Kenny DJ; Nicholson JK; Wilson ID; Kass IJ
    Bioanalysis; 2010 Oct; 2(10):1767-78. PubMed ID: 21083328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of the methods for measuring drugs and their metabolites].
    Ann Biol Clin (Paris); 1985; 43(4):543-57. PubMed ID: 4091315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in immunoassays for therapeutic drug monitoring.
    Marks V
    Antibiot Chemother (1971); 1979; 26():16-26. PubMed ID: 434791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.